{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-23",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 3
    }
  },
  "results": [
    {
      "discontinued_date": "02/25/2026",
      "update_type": "New",
      "initial_posting_date": "02/25/2026",
      "package_ndc": "0009-0395-14",
      "generic_name": "Clindamycin Hydrochloride Capsule",
      "contact_info": "844-646-4398",
      "related_info": "Discontinuation of the manufacture of the drug",
      "update_date": "02/25/2026",
      "therapeutic_category": [
        "Anti-Infective"
      ],
      "dosage_form": "Capsule",
      "presentation": "Cleocin Hydrochloride, Capsule, 300 mg (NDC 0009-0395-14)",
      "company_name": "Pfizer Inc.",
      "status": "To Be Discontinued"
    }
  ]
}